Opportunity remains despite regulatory and access obstacles.
Karina Ikeda
Advertisement
Karina Ikeda is a senior consultant within the life sciences practice at Guidehouse
Articles by Karina Ikeda
Advertisement
Latest Updated Articles
The JAKs Journey Offers Valuable Lessons for InnovatorsPublished: February 17th 2022 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
5
